Improved Diagnosis of Necrotizing Autoimmune Myopathy by Combinatorial Immune Assays



This webinar will discuss the diagnosis, pathological understanding, and current best treatment options for necrotizing autoimmune myopathy.


Photo of Christopher Klein, M.D.Christopher Klein, M.D.
Professor of Neurology
Mayo Clinic College of Medicine and Science
Division of Clinical Biochemistry and Clinical Genomics
Mayo Clinic, Rochester, Minnesota

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the clinical presentations of necrotizing autoimmune myopathy, also known as immune-mediated necrotizing myopathy.
  • Recognize the latest understanding of the autoimmune pathogenesis and therapeutic interventions.
  • Identify the current test platforms available to make the diagnosis and their clinical sensitivity and specificity.

Intended Audience

This webinar is designed for any provider who sees patients with a neurologic disease (e.g., neurologists, psychiatrists, and primary care physicians, including internists and family care practitioners) as well as pathologists, laboratory directors, and laboratory sendout coordinators.

Faculty Disclosure

Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.

Learn more about our testing

MCL Education

This post was developed by our Education and Technical Publications Team.